Don’t Miss
-
Cancellation of the WFH 2020 World Congress in Kuala Lumpur
It’s with great sadness—and heavy hearts—that we must inform you that the World Federation of Hemophilia has taken the difficult, but necessary, decision to cancel...
-
WFH corporate partner statements regarding the COVID-19 (coronavirus disease 2019) pandemic caused by SARS-CoV-2
The World Federation of Hemophilia (WFH) is monitoring the manufacturing, safety and supply of hemophilia therapies during the coronavirus pandemic. The WFH will be posting all...
-
COVID-19 (coronavirus disease 2019) pandemic caused by SARS-CoV-2: practical recommendations for people with hemophilia
From the World Federation of Hemophilia Medical Advisory Board (MAB)* and the WFH Medical Advisory Board and the WFH Coagulation Products Safety, Supply and Access Committee (CPSSAC)**: *MAB...
-
World Federation of Hemophilia Statement: Update to COVID-19
Since December 2019 the coronavirus, now known as COVID-19, has become an ongoing public health issue. The World Federation of Hemophilia (WFH) is committed to...
-
WFH WBDR 2018 Data Report now published
The WFH World Bleeding Disorders Registry (WBDR) 2018 Data Report now available! This report is based on 1,181 patients who were enrolled between January and December 2018. As of...
-
Now available: WFH Humanitarian Aid Program Impact Report 2018
A new report—called the “WFH Humanitarian Aid Program: Impact Report 2018”—has just been released. The document shows the impact that the WFH Humanitarian Aid Program...
